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Abstract: α-Luffin, found in Luffa cylindrica seeds, is a type I ribosome inactivating proteins. Cytotoxic effects make it an appropriate
candidate for the construction of immunotoxins and conjugates. Because of limited natural resources, recombinant technology is the
best approach to achieve large-scale production of plant-based proteins. In the present study, α-luffin protein was expressed in E. coli
and the effects of different temperature conditions, SUMO fusion tag, and cultivation strategies on total expression and solubility were
investigated. Protein expression was evaluated at different intervals (0, 4, 6, 8, 24 h) postinduction. Our results showed that EnBase had
higher efficiency than LB, and maximum solubility and total protein expression were achieved 24 h after induction at 30 °C and 25 °C,
respectively. It was shown that SUMO tag is an effective strategy to improve protein solubility.
Key words: E. coli expression system, fed-batch culture, ribosome inactivating proteins, soluble expression, α-luffin

1. Introduction
α-Luffin is a single-chain type I ribosome-inactivating
protein (RIP) found in Luffa cylindica seeds (Griffiths and
Electricwala, 1987; Ng et al., 1992a; Ma et al., 2012). α-Luffin
is one of three principle categories of RIPs identified from
plant resources that have structural differences: type I
RIPs consist of single chain polypeptides of approximately
30 kDa; type II category has an A chain catalytic domain
common with type I and a B chain binding domain
containing double chained RIPs of around 60 kDa (Lord et
al., 1994); type III RIPs, synthesized as inactive precursors,
undergo a proteolytic process before generating an active
RIP (Peumans et al., 2001). No clinical indications have yet
been reported for the third category, but type I RIPs have
been broadly studied in biomedical fields for targeted drug
delivery of immunotoxins in cancer immunotherapy.
RIPs, which inhibit protein synthesis by their rRNA
N glycosidases activity (Park et al., 2006), are widely
distributed among plants, bacteria, and fungi. RIPs have
been reported in approximately 17 different plant families,
including Cucurbitaceae, Poaceae, and Euphorbiaceae

(Sharma et al., 2004). RIPs show some properties including
antibacterial (Pelegrini et al., 2008), antifungal (Parkash
et al., 2002), and a multiplicity of antitumor (Cao et al.,
2012; Shin et al., 2013), abortifacient (Yeung et al., 1988),
and antiviral (for example, polio virus, cytomegalo virus,
influenza virus, herpes simplex virus, and anti-human
immunodeficiency virus (HIV)) activities (Barbieri et
al., 1993; Park et al., 2006; Au et al., 2014). RIPs have
attracted a lot of attention in biomedical research,
especially immunotoxins in targeted therapy studies
(Battelli et al., 1996). RIPs have been linked with carriers
such as antibodies and hormones, in order to make them
selectively toxic to a target cell. Numerous studies have
been carried out to examine novel recombinant RIPs with
desirable properties but, because of RIPs’ cellular toxicity,
the expression of recombinant RIPs is a complicated
process.
Some results suggested that α-luffin inhibited the
proliferation of cancer cell lines in a time- and dosedependent manner and it was shown that the morphology
of RIP-treated cells is similar to that of cells undergoing
death by apoptosis (Griffiths et al., 1987).
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Cancer is one of the therapeutic indications that have
benefited more from recombinant drugs. In this field,
antibodies designed for cancer cell eradication were used
for targeted cancer therapy (Thomas et al., 2016). The
monoclonal antibodies (mAb) linked to different cytotoxic
agents have made a second generation of antibodies
with considerable success in oncology. To date, only one
immunotoxin, denileukin diftitox (DD; Ontak), has been
approved by the US Food and Drug Administration (FDA)
(Goldmacher and Kovtun, 2011; Flygare et al., 2013;
Thomas et al., 2016).
The expression of a desired recombinant protein
seemed to be more reasonable using a suitable expression
system. The first FDA approved biopharmaceutical
(Insulin) was produced in Escherichia coli, in 1982.
Nowadays about 30% of biopharmaceuticals are produced
in the bacterial cells. Moreover, 24% (94 products) of
marketed biopharmaceuticals are used in anticancer
therapies and 69% of these products are produced in E. coli
(Sanchez-Garcia et al., 2016). According to the Southeast
Collaboratory for Structural Genomics (SECSG) reports,
22.9% of proteins that have been expressed in E. coli are in
soluble form. Coexpression with foldases and chaperones
(Ikura et al., 2002), using weaker promoters (Studier and
Moffatt, 1986), reducing the temperature, optimizing the
cultivation strategies, and protein fusions technology
are some of numerous strategies that may improve the
solubility of expressed proteins.
Thioredoxin (TRX), NUS A, maltose binding protein
(MBP), glutathione S-transferase (GST), ubiquitin (UB),
and small ubiquitin-related modifier protein (SUMO)
(Pryor and Leiting, 1997) are the most commonly used
tags. These fusion motifs can improve correct protein
folding and enhance the expression level and solubility rate
of recombinant proteins. SUMO, around 11 kDa, belongs
to a group of ubiquitin-like proteins that are mostly used by
fusing to the N-terminal of the protein of interest (POI) to
enhance its expression and solubility (Bird, 2011). SUMO
is involved in cellular processes like apoptosis, nuclear–
cytosolic transport, protein activation, and controlling the
eukaryotic cell cycle. Fusion proteins need to be cleaved
after expression, to promote native protein structure
(Lee et al., 2008). SUMO protease can recognize the 3D
structure of SUMO and cleave precisely within the amino
acid sequence of target proteins. Reducing proteolytic
degradation of the recombinant protein and simplifying
the purification process are other advantages of SUMO
fusion technology. Recombinant protein expression in E.
coli, using SUMO, has increased the yield of difficult-toexpress proteins (Shimokawa-Falcao et al., 2017).
In the present study, the recombinant α-luffin was
expressed in E.coli. In addition, the effect of SUMO fusion
tag, reduced temperature, and the cultivation strategy on
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its total and soluble expression was studied. Furthermore,
because of the toxic properties of α-luffin, we used
rhamnose promoter for tightly controlling the expression
and preventing overexpression of this protein.
2. Materials and methods
2.1. Cloning of α-luffin gene
According to sequence data in GenBank, the α-luffin
gene with accession number X62371.1 was chemically
synthesized, after codon optimization for protein
expression in E. coli cells. Forward and reverse primers
were designed based on the protocol of the Lucigen kit
(Lucigen Corporation, USA). Amplification was achieved
through polymerase chain reaction (PCR). The PCR
products were analyzed by agarose gel electrophoresis. The
expected size of PCR product was 750 bp.
After the amplification of the target gene, 1–3 μL
of PCR product was mixed with 25 ng of pRham N-His
SUMO Vector and transformed into E. coli 10G, chemically
competent cells of the Lucigen kit. Transformation was
performed according to the manufacturer’s instructions.
Recombination between the vector and α-luffin gene
occurred in vivo, within the bacterial host.
2.2. Screening for recombinants
To confirm the recombination, the colonies were picked
from a freshly prepared selective plate and plasmid
extraction was performed using a Fermentas Gene JET
plasmid miniprep kit according to the manufacturer’s
instructions. The extracted plasmids were subjected
to colony PCR and restriction enzyme digestion. PCR
amplification was carried out using the specific primers
and SUMO forward and pETite reverse primers included
in the kit. PCR cycles were as follow: 25 cycles of 94 °C for
45 s, 55 °C for 45 s, and 72 °C for 45 s. The expected PCR
product size was 750 bp. The PCR products were analyzed
by agarose gel electrophoresis. Recombinant plasmid was
also digested using EcoRV.
2.3. Protein expression
A single colony of recombinant E. coli 10G was inoculated
into LB growth medium containing 30 µg/mL kanamycin
at 37 °C with 180 rpm shaking. After 3–4 h, when the
OD600 of the culture reached 0.55–0.6, 1 mL of medium
was centrifuged and kept at –20 °C as a negative control.
Then 0.2% rhamnose was added to the remaining cells to
induce expression. Bacterial pellets were collected 4, 6, 8,
and 24 h after incubation.
2.4. α-Luffin expression analysis
For detection of recombinant expression, SDS-PAGE
and western blot analysis were performed. Induced cells
were harvested and resuspended in 2X sample buffer
(0.5 M Tris base pH 6.8, 25% glycerol, 4% SDS, 0.5%
bromophenol blue). Samples were heated in a water bath
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in 95 °C for 5–10 min and analyzed on 12% SDS-PAGE
with Coomassie Brilliant Blue staining.
Western blotting was performed utilizing an anti-His
antibody. The separated proteins were then transferred
to a nitrocellulose membrane at 14 V for 40 min. The
membrane was blocked with 3% nonfat dry milk in
phosphate-buffered saline (PBS)-0.05% Tween 20 for 2 h.
Then blots were incubated with the antibody at a dilution
of 1:500 in PBS for 2 h at room temperature.
Visualization of the HRP-conjugated antibody was
achieved using the DAB substrate. An 18 kDa Hisconjugated protein and uninduced cells were used as the
positive and negative controls, respectively.
2.5. Effects of cultivation strategies and reduced
temperatures on α-luffin expression/solubility
According to the Biosilta kit protocol for fed-batch Enbase
cultivation, EnPresso two white tablets, containing culture
media component, were solved in 50 mL of pure, distilled,
and sterile water. For preparing the preculture, a single
colony was inoculated in 5 mL of LB containing 30 µg/
mL kanamycin and incubated for 6–8 h at 37 °C to obtain
OD600 0.6 approximately, at which time 1:25 volume of
the preculture medium was inoculated into the 5 mL of
prepared EnBase culture medium supplemented with
kanamycin (30 µg/mL). Then 12.5 µL of 600 IU Reagent
A (glucose releasing enzyme) was added and the culture
was incubated overnight with shaking at 200 rpm. After
15–18 h, 1 mL of grown medium was collected as before
induction sample. According to the manufacturer’s
instruction, in this step, a booster tablet (black tablet) was
added. The booster tablet was composed of extra nutrients
and polysaccharide substrate. Each tablet was solved in
5 mL of distilled sterile water and 0.5 mL of prepared
medium was used in each study. Moreover, 12.5 µL of 600
IU Reagent A and rhamnose (at final concentration of
0.2%) were also added to the cultivation medium. Samples
were collected 2, 4, 6, 8, 12, and 24 h after induction. The
media were centrifuged and pellets were stored at –20 °C
until further analysis.
The mentioned steps were repeated at two other
induction temperatures, 25 °C and 30 °C, to investigate
the influence of reduced temperature on solubility of
recombinant α-luffin.
2.6. Soluble expression analysis
In order to assess the solubility of recombinant α-luffin,
samples were centrifuged at 9000 rpm for 3 min. Cell
pellets were resuspended in TE buffer and sonicated for
8 cycles of 30 s pulses and 20 s intervals. The sonicated
samples were centrifuged at 13,000 rpm for 20 min at 4
°C. The total protein sample was collected from the cell
suspension after sonication. The clear supernatant was
collected as a soluble fraction after the insoluble debris
was pelleted. Protein concentration was measured using

absorbance at 280 nm by NanoDrop spectrophotometer.
Total, pellet, and supernatant samples of each experiment
were subjected to SDS-PAGE and protein bands were
visualized by staining with Coomassie Brilliant Blue.
3. Results
3.1. Gene cloning
The successful cloning of coding sequences into pRham
N-His SUMO plasmid was confirmed by restriction
enzyme digestion and colony PCR. The results of the
digestion and the final map of the recombinant plasmid
are shown in Figure 1. The restriction analysis of pRham
N-His SUMO-α-luffin using EcoRV resulted in expected
bands of 1364 and 1934 bp. Similarly, PCR product with
predicted size of 750 bp was amplified from extracted
plasmid (Figure 2).
3.2. SDS-PAGE and western blot analysis
As shown in Figure 3, SDS-PAGE analysis revealed the
N-His SUMO-α-luffin fusion protein with the expected
molecular weight of 42 kDa in the recombinant E. coli
10G clones. Further analysis by western blotting detection
was performed according to Figure 4, which showed the
reaction of an anti-His IgG with this band and no band
was observed in the negative control cells. These results
confirmed that α-luffin protein was successfully expressed
in E. coli cells.
3.3. Analysis of fed-batch system effects on expression
and solubility of α-luffin
To evaluate the influence of cultivation strategy on protein
expression, EnBase fed-batch system and LB medium were
compared. The recombinant E. coli 10G cells were induced
at 37 °C and the collected pellets (0–24 h after induction)
were sonicated. The total α-luffin expression was analyzed
on 12% resolving gel. Our results demonstrated that the
EnBase fed-batch system supports higher expression level
of α-luffin than LB medium (Figure 5). Further analysis
was carried out using EnBase medium.
3.4. Analysis of reduced temperature effects on expression
and solubility of α-luffin
The effect of reducing temperature on total and soluble
expression of α-luffin was investigated at 25 °C, 30 °C,
and 37 °C. To identify the optimum length of induction,
the recombinant bacteria were induced for 4, 6, 8, 12,
and 24 h at each temperature. The distribution of the
recombinant SUMO α-luffin protein in total, pellet, and
supernatant samples was studied using SDS-PAGE. As
shown in Figure 6, the highest expression level in the
EnBase cultivation system was achieved at 25 °C. The
results also indicated that the majority of expressed
α-luffin at 37 °C formed inclusion bodies. However, at 30
°C and 25 °C, the recombinant protein was detected in
both soluble and insoluble fractions. The maximum level
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Figure 1. Analysis of pFUSE pRham N-His SUMO-α-luffin recombinant plasmid by restriction enzyme digestion. A) According
to the plasmid map, predicted product sizes were 1364 and 1934 bp. B) Gel-electrophoresis analysis of the pFUSE pRham N-His
SUMO-α-luffin plasmid by EcoRV restriction enzyme digestion on a 0.8% agarose gel. Lane 1: digested N-His SUMO-α-luffin; lane
2: undigested N-His SUMO-α-luffin; lane 3: 1 kb DNA markers.

Figure 2. PCR analysis of extracted recombinant plasmids from kanamycin-resistant
E. coli cells. PCR products were electrophoresed on a 0.8% agarose gel. Lanes 1 and 2:
amplification of α-luffin gene; lane 3: negative control; lane 4: 1 kb DNA markers.
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Figure 3. SDS-PAGE analysis of α-luffin expression in LB medium. Lane 1: Cell
lysates before rhamnose induction; Lane 2: Cell lysates 4 h postinduction; Lane 3:
Cell lysates 6 h postinduction; Lane 4: Cell lysates 8 h postinduction; Lane 5: Cell
lysates 24 h postinduction; Lane 6: Fermentas Protein marker SM0671.

Figure 4. Western blot analysis of recombinant His tag-α-luffin. Lane
1: 42 kDa His tagged α-luffin; Lane 2: His tagged protein as positive
control; Lane 3: Fermentas protein marker SM0671.
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Figure 5. SDS-PAGE analysis of expressed recombinant SUMO/α-luffin at different temperatures and times in EnBase medium. The samples were
separated on 12% resolving gel under reduced condition. The gels were stained with Coomassie Blue. A) Coomassie stained gel under reduced condition,
EnBase medium at 37 °C. Lane 1: Cell lysates before rhamnose induction; Lane 2: Cell lysates 4 h postrhamnose induction; Lane 3: Cell lysates 6 h
postrhamnose induction; Lane 4: Cell lysates 8 h postrhamnose induction; Lane 5: Cell lysates 12 h postrhamnose induction; Lane 6: Cell lysates 24 h
postrhamnose induction; M: Fermentas protein marker SM0671. B) Coomassie stained gel under reduced condition, EnBase medium at 30 °C. Lane 1:
Cell lysates before rhamnose induction; Lane 2: Cell lysates 4 h postrhamnose induction; Lane 3: Cell lysates 6 h postrhamnose induction; Lane 4: Cell
lysates 8 h postrhamnose induction; Lane 5: Cell lysates 12 h postrhamnose induction; Lane 6: Cell lysates 24 h postrhamnose induction; M: Fermentas
protein marker SM0671. C) Coomassie stained gel under reduced condition, EnBase medium at 25 °C. Lane 1: Cell lysates before rhamnose induction;
Lane 2: Cell lysates 4 h postrhamnose induction; Lane 3: Cell lysates 6 h postrhamnose induction; Lane 4: Cell lysates 8 h postrhamnose induction; Lane
5: Cell lysates 12 h postrhamnose induction; Lane 6: Cell lysates 24 h postrhamnose induction; M: Fermentas protein marker SM0671.
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Figure 6. SDS-PAGE analysis of soluble and insoluble expression of recombinant SUMO/α-luffin expression at different temperatures and times in
EnBase medium. The samples were separated on 12% resolving gel under reduced condition. The gels were stained with Coomassie Blue. The distribution
of total cell lysates, pellet and soluble fractions during different time intervals post rhamnose induction. B = before induction by rhamnose, T = total
lysate, P = pellet, S = supernatant or soluble fraction, M: Fermentas protein marker. A) Coomassie stained gel under reduced condition. The distribution
of total cell lysates, pellet and soluble fractions during different time intervals post rhamnose induction at 37 °C in EnBase medium. B) Coomassie stained
gel under reduced condition. The distribution of total cell lysates, pellet and soluble fractions during different time intervals post rhamnose induction
at 30 °C in EnBase medium. C) Coomassie stained gel under reduced condition. The distribution of total cell lysates, pellet and soluble fractions during
different time intervals post rhamnose induction at 25 °C in EnBase medium.
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of soluble expression for α-luffin was attained 12 and 24 h
postinduction time at 30 °C.
As illustrated in Figures 5 and 6, the fed-batch system
and reduced temperature can improve expression and
solubility of α-luffin.
4. Discussion
Nowadays targeted therapy is one of the best strategies
in the treatment of cancer or other complicated diseases
(Battelli et al., 1996). Antibody drug conjugates (ADCs) are
a class of therapeutics consisting of the antigen-selectivity
of MAbs in order to deliver highly potent toxins to tumor
cell surface antigen (Trail, 2013). Many toxins have been
considered as candidates for producing antibody drug
conjugates (Flygare et al., 2013). For this approach, RIPs
have been linked to carriers such as antibodies, hormones,
and growth factors. RIPs containing immunotoxins
can act on cells without inducing resistance and so they
have more advantages in comparison to the conventional
chemotherapeutic agents (Sobiya Raj and Jannet Vennila,
2013).
α-Luffin, a type I RIP, is one of the most toxic proteins
from the luffin family. Several studies revealed its antiviral
effects. On the other hand, antitumoral activities of this
protein were confirmed in breast cancers, choriocarcinoma,
and hepatoma in different cell lines (Sha et al., 2013).
Regarding their highly toxic nature, RIP family toxins
have toxic effects on producing host cells. It especially
occurs in luffin-a and -b from Luffa cylindrica (cytotoxic
derivatives) (Ng et al., 1992a, 1992b; Ma et al., 2012).
Escherichia coli has been the workhorse of gene
expression for many years, but unfortunately cytoplasmic
expression of many recombinant toxins mostly has led
to inclusion bodies formation, requiring comprehensive
in vitro refolding steps to access their biological
activities (Balduino et al., 2011; Lyukmanova et al., 2016;
Shimokawa-Falcao et al., 2017). On the other hand,
the refolding process is not cost effective in many cases;
therefore enhancing protein solubility by other strategies
is a better approach to obtain high production levels (Lee
et al., 2008). In the present study, we aimed to enhance
the total and soluble expression of α-luffin by reducing the
induction temperature, fed-batch cultivation system, and
SUMO fusion tag. Moreover, because of the toxic effect of
recombinant α-luffin, the tunable rhamnose promoter was
used.
First, the expression of recombinant α-luffin was
confirmed at 37 °C in LB medium (Figures 3 and 4), and
the total protein expression was not significantly altered
at different times postinduction. However, in EnBase
medium, the expression of recombinant protein increased
with time postinduction, and maximum expression
and solubility were obtained 12 and 24 h postinduction.
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EnBase medium provides a controlled cultivation mode by
continuous feeding with glucose, controlling pH changes,
avoiding oxygen fluctuations, and other controlling
processes on growth medium conditions (PanulaPerälä et al., 2008). Hence, the E. coli cells survived the
harmful effect of metabolites and oxygen depletion
and protein synthesis reduction (Krause et al., 2010).
A similar outcome was reported by Krause et al., who
developed a novel fed-batch based cultivation method.
They demonstrated that the novel EnBase Flo cultivation
system in shaken cultures can provide high cell densities
without impairing the productivity per cell and improve
yield of soluble recombinant proteins in shaken cultures
in comparison to commonly used LB, Terrific broth, or
mineral salt media (Krause et al., 2010). Due to the growth
control in the EnBase cultivation system, accumulation of
harmful metabolites can be diminished and development
of anaerobic conditions can be avoided. Expression at
three different temperatures, 25 °C, 30 °C, and 37 °C, was
investigated. Samples were collected 0–24 h after induction
by rhamnose.
Some previous studies have reported the toxic effect
of RIPs on prokaryotic ribosomes (Girbes et al., 1993;
Chaddock et al., 1994; Liu et al., 2010). Our observations did
not show this phenomenon because of lower temperature
cultivation (25 °C), which could reduce the toxic effect
of α-luffin on E. coli cells only if it is performed in fedbatch mode. It may be explained by the fact that EnBase
fed-batch mode supports high cell density by slow release
of an essential nutrient (glucose). Furthermore, at 25 °C
24 h postinduction, OD600 is about twofold more than in a
previous study at the same temperature and the same time
in EnBase medium (unpublished data). We suggested that
rhamnose promoter has an effective role on controlling the
expression of recombinant α-luffin protein by its tunable
mechanism of action. Although the rhamnose promoter is
weaker than T7, lower expression of the α-luffin happens
by this promoter and E. coli cells could survive the toxic
effect of α-luffin and keep on the expression of recombinant
protein up to 24 h postinduction. On the other hand, by
using the rhamnose promoter system we prevent leaky
expression in before induction samples that happened in
the previous study with T7 promoter (unpublished data).
Furthermore, as illustrated in Figures 5 and 6, the
highest level of total expression and soluble form was
obtained at 25 °C and 30 °C, respectively. At lower
temperatures, the number of functional ribosomes and
level of protein synthesis in the cell are increased to
compensate for the decrease in translational activity
and α-luffin is a ribosome inactivating protein and so
when more ribosomes are available the inhibiting effect
is probably prevented (Yun et al., 1996). Therefore, the
ribosome inhibitory toxic effect is less apparent at low
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temperature cultivation. Furthermore, hydrophobic
reactions that make inclusion bodies and aggregation of
the recombinant proteins happen less (Krause et al., 2010)
and for this reason a higher soluble form of α-luffin was
achieved at 30 °C and 25 °C in comparison to 37 °C. On
the other hand, the chaperone-like manner of SUMO tag
and high activity of chaperones at 30 °C can improve the
solubility rate of α-luffin (Rezaie et al., 2017).
In conclusion, the mature α-luffin gene was cloned
and the recombinant α-luffin was successfully expressed
in E. coli. Different induction parameters, such as growth
temperature and incubation time, have been modified

to improve the expression levels of α-luffin especially in
soluble form. The results revealed that a maximum yield
of total protein expression was achieved by induction
with 0.2% rhamnose and 24 h after induction at 25 °C.
Furthermore, our data showed that the highest level of
soluble protein expression was achieved at 30 °C in EnBase
cultivation medium.
Acknowledgment
This work was supported by a grant from Biotechnology
Research Center, Pasteur Institute of Iran.

References
Au KY, Wang RR, Wong YT, Wong KB, Zheng YT, Shaw PC
(2014). Engineering a switch-on peptide to ricin A chain for
increasing its specificity towards HIV-infected cells. Biochim
Biophys Acta 1840: 958-963.
Balduino KN, Spencer PJ, Malavasi NV, Chura-Chambi RM,
Lemke LS, Morganti L (2011). Refolding by high pressure of
a toxin containing seven disulfide bonds: Bothropstoxin-1
from Bothrops jararacussu. Molecular Biotechnology 48:
228-234.
Barbieri L, Battelli MG, Stirpe F (1993). Ribosome-inactivating
proteins from plants. Biochim Biophys Acta 21: 3-4.
Battelli MG, Polito L, Bolognesi A, Lafleur L, Fradet Y, Stirpe
F (1996). Toxicity of ribosome-inactivating proteinscontaining immunotoxins to a human bladder carcinoma
cell line. Int J Cancer 65: 485-490.
Bird LE (2011). High throughput construction and small scale
expression screening of multi-tag vectors in Escherichia coli.
Methods 55: 29-37.
Cao Y, Marks JD, Huang Q, Rudnick SI, Xiong C, Hittelman WN,
Wen X, Marks JW, Cheung LH, Boland K, Li C et al (2012).
Single-chain antibody-based immunotoxins targeting Her2/
neu: design optimization and impact of affinity on antitumor
efficacy and off-target toxicity. Mol Cancer Ther 11: 143-153.
Chaddock JA, Lord JM, Hartley MR, Roberts LM (1994).
Pokeweed antiviral protein (PAP) mutations which permit
E. coli growth do not eliminate catalytic activity towards
prokaryotic ribosomes. Nucleic Acids Res 22: 1536-1540.
Flygare JA, Pillow TH, Aristoff P (2013). Antibody-drug conjugates
for the treatment of cancer. Chem Biol Drug Des 81: 113-121.
Girbes T, Barbieri L, Ferreras M, Arias FJ, Rojo MA, Iglesias R,
Alegre C, Escarmis C, Stirpe F (1993). Effects of ribosomeinactivating proteins on Escherichia coli and Agrobacterium
tumefaciens translation systems. J Bacteriol 175: 6721-6724.
Goldmacher VS, Kovtun YV (2011). Antibody-drug conjugates:
using monoclonal antibodies for delivery of cytotoxic
payloads to cancer cells. Ther Deliv 2: 397-416.

Griffiths GD, Leek MD, Gee DJ (1987). The toxic plant proteins
ricin and abrin induce apoptotic changes in mammalian
lymphoid tissues and intestine. J Pathol 151: 221-229.
Griffiths JB, Electricwala A (1987). Production of tissue plasminogen
activators from animal cells. Adv Biochem Eng Biotechnol 34:
147-166.
Ikura K, Kokubu T, Natsuka S, Ichikawa A, Adachi M, Nishihara
K, Yanagi H, Utsumi S (2002). Co-overexpression of folding
modulators improves the solubility of the recombinant guinea
pig liver transglutaminase expressed in Escherichia coli. Prep
Biochem Biotechnol 32: 189-205.
Krause M, Ukkonen K, Haataja T, Ruottinen M, Glumoff T, Neubauer
A, Neubauer P, Vasala A (2010). A novel fed-batch based
cultivation method provides high cell-density and improves
yield of soluble recombinant proteins in shaken cultures.
Microb Cell Fact 9: 11.
Lee CD, Sun HC, Hu SM, Chiu CF, Homhuan A, Liang SM, Leng
CH, Wang TF (2008). An improved SUMO fusion protein
system for effective production of native proteins. Protein Sci
17: 1241-1248.
Liu L, Wang R, He W, He F, Huang G (2010). Cloning and soluble
expression of mature alpha-luffin from Luffa cylindrica and
its antitumor activities in vitro. Acta Biochim Biophys Sin
(Shanghai) 42: 585-592.
Lord JM, Roberts LM, Robertus JD (1994). Ricin: structure, mode
of action, and some current applications. FASEB J 8: 201-208.
Lyukmanova EN, Shulepko MA, Shenkarev ZO, Kasheverov IE,
Chugunov AO, Kulbatskii DS, Myshkin MY, Utkin YN,
Efremov RG, Tsetlin VI et al (2016). Central loop of nonconventional toxin WTX from Naja kaouthia is important
for interaction with nicotinic acetylcholine receptors. Toxicon
119: 274-279.
Ma C, Li Y, Li Z, Huang H, Xu K, Xu H, Bai J, Li X, Zhao G (2012).
Synthesis and purification of a toxin-linked conjugate targeting
epidermal growth factor receptor in Escherichia coli. Protein
Expr Purif 83: 1-7.

31

NAMVAR et al. / Turk J Biol
Ng TB, Chan WY, Yeung HW (1992a). Proteins with abortifacient,
ribosome inactivating, immunomodulatory, antitumor
and anti-AIDS activities from Cucurbitaceae plants. Gen
Pharmacol 23: 579-590.
Ng TB, Wong RN, Yeung HW (1992b). Two proteins with
ribosome-inactivating, cytotoxic and abortifacient activities
from seeds of Luffa cylindrica Roem. (Cucurbitaceae).
Biochem Int 27: 197-207.
Panula-Perälä J, Šiurkus J, Vasala A, Wilmanowski R, Casteleijn
MG, Neubauer P (2008). Enzyme controlled glucose autodelivery for high cell density cultivations in microplates and
shake flasks. Microbial Cell Factories 7: 31.
Park SW, Prithiviraj B, Vepachedu R, Vivanco JM (2006). Isolation
and Purification of Ribosome-Inactivating Proteins. In:
Loyola-Vargas VM, Vázquez-Flota F, editors. Plant Cell
Culture Protocols. Totowa, NJ, USA: Humana Press, pp. 335347.
Parkash A, Ng TB, Tso WW (2002). Isolation and characterization
of luffacylin, a ribosome inactivating peptide with antifungal activity from sponge gourd (Luffa cylindrica) seeds.
Peptides 23: 1019-1024.
Pelegrini PB, Murad AM, Silva LP, Dos Santos RC, Costa FT,
Tagliari PD, Bloch C Jr, Noronha EF, Miller RN, Franco OL
(2008). Identification of a novel storage glycine-rich peptide
from guava (Psidium guajava) seeds with activity against
Gram-negative bacteria. Peptides 29: 1271-1279.
Peumans WJ, Hao Q, Van Damme EJ (2001). Ribosome-inactivating
proteins from plants: more than RNA N-glycosidases? FASEB
J 15: 1493-506.
Pryor KD, Leiting B (1997). High-level expression of soluble
protein in Escherichia coli using a His6-Tag and maltosebinding-protein double-affinity fusion system. Protein Expr
Purif 10: 309-319.
Rezaie F, Davami F, Mansouri K, Amiri SA, Fazel R, Mahdian R,
Davoudi N, Enayati S, Azizi M, Khalaj V (2017). Cytosolic
expression of functional Fab fragments in Escherichia coli
using a novel combination of dual SUMO expression cassette
and EnBase® cultivation mode. J Appl Microbiol 123: 134144.

32

Sanchez-Garcia L, Martín L, Mangues R, Ferrer-Miralles N, Vázquez
E, Villaverde A (2016). Recombinant pharmaceuticals from
microbial cells: a 2015 update. Microbial Cell Factories 15: 33.
Sha O, Niu J, Ng TB, Cho EYP, Fu X, Jiang W (2013). Anti-tumor
action of trichosanthin, a type 1 ribosome-inactivating protein,
employed in traditional Chinese medicine: a mini review.
Cancer Chemother Pharmacol 71: 1387-1393.
Sharma N, Park SW, Vepachedu R, Barbieri L, Ciani M, Stirpe F,
Savary BJ, Vivanco JM (2004). Isolation and characterization
of an RIP (ribosome-inactivating protein)-like protein from
tobacco with dual enzymatic activity. Plant Physio 134: 171181.
Shimokawa-Falcao LH, Caporrino MC, Barbaro KC, Della-Casa
MS, Magalhaes GS (2017). Toxin fused with SUMO tag: a new
expression vector strategy to obtain recombinant venom toxins
with easy tag removal inside the bacteria. Toxins (Basel) 9.
Shin MC, Zhang J, David AE, Trommer WE, Kwon YM, Min
KA, Kim JH, Yang VC (2013). Chemically and biologically
synthesized CPP-modified gelonin for enhanced anti-tumor
activity. J Control Release 172: 169-178.
Sobiya Raj D, Jannet Vennila J (2013). Progress in ribosomal
inactivating protein (RIP) studies: recent review of potential
applications. International Journal of Pharmacy and Biological
Sciences 3: 88-100.
Studier FW, Moffatt BA (1986). Use of bacteriophage T7 RNA
polymerase to direct selective high-level expression of cloned
genes. J Mol Biol 189: 113-130.
Thomas A, Teicher BA, Hassan R (2016). Antibody-drug conjugates
for cancer therapy. Lancet Oncol 17: e254-262.
Trail P (2013). Antibody drug conjugates as cancer therapeutics.
Antibodies 2: 113.
Yeung HW, Li WW, Feng Z, Barbieri L, Stirpe F (1988). Trichosanthin,
alpha-momorcharin and beta-momorcharin: identity of
abortifacient and ribosome-inactivating proteins. Int J Pept
Protein Res 31: 265-268.
Yun HS, Hong J, Lim HC (1996). Regulation of ribosome synthesis
in Escherichia coli: effects of temperature and dilution rate
changes. Biotechnol Bioeng 52: 615-624.

